Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chaitanya Institute of Regenerative Medicine is a clinical research and treatment center located in Pune, India, specializing in stem cell therapy. The institute focuses on providing regenerative solutions for complex neurological and musculoskeletal disorders that have limited conventional treatment options. Their primary therapeutic approach involves the use of autologous bone marrow-derived mononuclear cells to promote tissue repair and functional recovery. Key indications treated at the facility include autism spectrum disorder, cerebral palsy, spinal cord injuries, and various forms of muscular dystrophy. The center operates with a focus on clinical application, offering patient-centric care alongside ongoing observational research. By integrating advanced cell processing techniques with specialized rehabilitation, the institute aims to enhance the developmental and physical outcomes for its patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chaitanya Institute of Regenerative Medicine.